Clinical Trials Browser

Phase 3 × OTHER × Non-Muscle Invasive Bladder Neoplasms × Clear all

Non-Muscle Invasive Bladder Neoplasms

NCT07000084 2026-04-07

GAIN-BCG

Phase 3 Recruiting

330 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07268339 2025-12-05

TRAIN

Phase 3 Not yet recruiting

328 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07207824 2025-10-06

HERO

Phase 3 Not yet recruiting

182 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06696794 2025-02-19

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Phase 3 Recruiting

180 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06327932 2024-03-25

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Phase 3 Not yet recruiting

320 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02695771 2023-04-21

BIC

Phase 3 Completed

101 enrolled 11 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01149174 2011-10-04

EMDA/PRE-TUR

Phase 3 Completed

352 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

GAIN-BCG

TRAIN

HERO

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

BIC

EMDA/PRE-TUR